Orrick Expands Life Sciences and Tech VC Practice in Boston with Key Hires

Orrick has bolstered its presence in the life sciences and tech venture capital sectors by adding partners Mark Solakian and Jake Gatof to its Boston office. These new hires are intended to enhance Orrick's growth strategy in the critical Boston market, particularly within the life sciences sector. Mark Solakian and Jake Gatof bring extensive experience and connections within the Boston tech and life sciences ecosystem. Solakian has served in significant roles at notable biotech firms, while Gatof has a track record with biotech, digital health, and medical device companies. This expansion is part of Orrick's broader strategy to establish a world-class, cross-disciplinary practice in life sciences and healthtech, alongside previous investments in other tech teams across the United States. Orrick aims to address the increasing demand for legal expertise in regulatory uncertainties, financing, strategic collaborations, and intellectual property within these industries. The appointment of Solakian and Gatof reflects Orrick’s commitment to expanding its capabilities and offerings in these sectors, leveraging Boston’s prime position in the life sciences and tech industries.